Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells
Signals transmitted by binding of Fas ligand (FasL) to the Fas receptor (CD95/Apo-1) have pleiotropic effects on cellular function that present opportunities for therapeutic applications. For example, depending on the circumstances, overexpression of FasL can enhance, prevent, or reverse growth of s...
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 112(2004), 1 vom: 16. Juli, Seite 54-65 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , , |
Format: | Aufsatz |
Sprache: | English |
Veröffentlicht: |
2004
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
Schlagworte: | Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Fas Ligand Protein Fasl protein, mouse Membrane Glycoproteins |